Literature DB >> 18816678

What is the role and significance of serum and stool biomarkers in the diagnosis of IBD?

Ron Palmon1, Steven J Brown, Maria T Abreu.   

Abstract

Biomarkers hold promise for identifying high-risk individuals who may go on to develop IBD as well as prognosticate disease behavior. Stool markers have not been readily accepted but may be more sensitive and specific than our serum biomarkers for evaluating disease activity. Ultimately, genomic and proteomic approaches will be used to identify novel biomarkers in IBD.

Mesh：

Substances：

Year:  2008        PMID： 18816678     DOI： 10.1002/ibd.20714

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


  3 in total

1.  Predictors of aggressive inflammatory bowel disease.

Authors:  Andres J Yarur; Sebastian G Strobel; Amar R Deshpande; Maria T Abreu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-10

2.  Plasma citrulline as surrogate marker of intestinal inflammation in pediatric and adolescent with Crohn's disease: preliminary report.

Authors:  Antonella Diamanti; Daniela Knafelz; Fabio Panetta; Fiammetta Bracci; Manuela Gambarara; Bronislava Papadatou; Antonella Daniele; Bianca M Goffredo; Simona Pezzi; Giuliano Torre
Journal:  Int J Colorectal Dis       Date:  2011-06-14       Impact factor: 2.571

3.  A new model for the discrimination between ulcerative colitis and Crohn's disease.

Authors:  Zhe Shen; Wei-Ping Ma; Xiao-Na Shao; Chao-Hui Yu; Juan Du; Zun Xiang; Gan-Hua Guo; Hong Zhang; You-Ming Li; Min Yue
Journal:  Int J Clin Exp Med       Date:  2015-01-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.